[HTML][HTML] Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with …

A Sheikh, S Kerr, M Woolhouse… - The Lancet Infectious …, 2022 - thelancet.com
Background Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested …

A Sheikh, S Kerr, M Woolhouse… - The Lancet …, 2022 - abdn.elsevierpure.com
Background Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested …

EAVE II Collaborators - The Lancet Infectious Diseases, 2022 - research.ed.ac.uk
Background: Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

[HTML][HTML] Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with …

A Sheikh, S Kerr, M Woolhouse… - The Lancet. Infectious …, 2022 - ncbi.nlm.nih.gov
Background Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested …

A Sheikh, S Kerr, M Woolhouse… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested …

A Sheikh, S Kerr, M Woolhouse… - Lancet Infectious …, 2022 - pureportal.strath.ac.uk
Background: Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested …

A Sheikh, S Kerr, M Woolhouse… - Lancet Infectious …, 2022 - strathprints.strath.ac.uk
Background: Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

[HTML][HTML] Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with …

A Sheikh, S Kerr, M Woolhouse, J McMenamin… - The Lancet Infectious …, 2022 - Elsevier
Background Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested …

A Sheikh, S Kerr, M Woolhouse, J McMenamin… - 2022 - cabidigitallibrary.org
Background: Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …

Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested …

A Sheikh, S Kerr, M Woolhouse… - The Lancet. Infectious …, 2022 - europepmc.org
Background Since its emergence in November, 2021, in southern Africa, the SARS-CoV-2
omicron variant of concern (VOC) has rapidly spread across the world. We aimed to …